Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura W Dillon

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Leukemia|May 25, 2024
TP53 mutation screening for patients at risk of myeloid malignancyDevdeep Mukherjee, Rialnat A Lawal, Courtney D Fitzhugh, et al.
Human Molecular Genetics|January 9, 2013
Role of DNA secondary structures in fragile site breakage along human chromosome 10Laura W Dillon, Levi C T Pierce, Maggie C Y Ng, et al.
Molecular Cancer Research : MCR|May 28, 2017
Normal and Cancerous Tissues Release Extrachromosomal Circular DNA (eccDNA) into the CirculationPankaj Kumar, Laura W Dillon, Yoshiyuki Shibata, et al.
Plos One|September 17, 2013
DNA topoisomerases participate in fragility of the oncogene RETLaura W Dillon, Levi C T Pierce, Christine E Lehman, et al.
Haematologica|September 2, 2018
Targeted RNA-sequencing for the quantification of measurable residual disease in acute myeloid leukemiaLaura W Dillon, Sheida Hayati, Gregory W Roloff, et al.
Frontiers in Immunology|May 14, 2023
Prediction of HLA genotypes from single-cell transcriptome dataBenjamin D Solomon, Hong Zheng, Laura W Dillon, et al.
Cell Reports|June 9, 2015
Production of Extrachromosomal MicroDNAs Is Linked to Mismatch Repair Pathways and Transcriptional ActivityLaura W Dillon, Pankaj Kumar, Yoshiyuki Shibata, et al.
Blood|August 31, 2022
Increased incidence of hematologic malignancies in SCD after HCT in adults with graft failure and mixed chimerismRialnat A Lawal, Devdeep Mukherjee, Emily M Limerick, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2023
Persistent <i>IDH</i> mutations are not associated with increased relapse or death in patients with <i>IDH</i>-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamideNiveditha Ravindra, Laura W Dillon, Gege Gui, et al.
Bone Marrow Transplantation|January 5, 2024
Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamideNiveditha Ravindra, Laura W Dillon, Gege Gui, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Leukemia|May 25, 2024
TP53 mutation screening for patients at risk of myeloid malignancyDevdeep Mukherjee, Rialnat A Lawal, Courtney D Fitzhugh, et al.
Human Molecular Genetics|January 9, 2013
Role of DNA secondary structures in fragile site breakage along human chromosome 10Laura W Dillon, Levi C T Pierce, Maggie C Y Ng, et al.
Molecular Cancer Research : MCR|May 28, 2017
Normal and Cancerous Tissues Release Extrachromosomal Circular DNA (eccDNA) into the CirculationPankaj Kumar, Laura W Dillon, Yoshiyuki Shibata, et al.
Plos One|September 17, 2013
DNA topoisomerases participate in fragility of the oncogene RETLaura W Dillon, Levi C T Pierce, Christine E Lehman, et al.
Haematologica|September 2, 2018
Targeted RNA-sequencing for the quantification of measurable residual disease in acute myeloid leukemiaLaura W Dillon, Sheida Hayati, Gregory W Roloff, et al.
Frontiers in Immunology|May 14, 2023
Prediction of HLA genotypes from single-cell transcriptome dataBenjamin D Solomon, Hong Zheng, Laura W Dillon, et al.
Cell Reports|June 9, 2015
Production of Extrachromosomal MicroDNAs Is Linked to Mismatch Repair Pathways and Transcriptional ActivityLaura W Dillon, Pankaj Kumar, Yoshiyuki Shibata, et al.
Blood|August 31, 2022
Increased incidence of hematologic malignancies in SCD after HCT in adults with graft failure and mixed chimerismRialnat A Lawal, Devdeep Mukherjee, Emily M Limerick, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2023
Persistent <i>IDH</i> mutations are not associated with increased relapse or death in patients with <i>IDH</i>-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamideNiveditha Ravindra, Laura W Dillon, Gege Gui, et al.
Bone Marrow Transplantation|January 5, 2024
Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamideNiveditha Ravindra, Laura W Dillon, Gege Gui, et al.
Pageof 5